IMARC Group, a leading market research company, has recently releases report titled “Cell and Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global cell and gene therapy market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the cell and gene therapy market?
The global cell and gene therapy market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 43.0 Billion by 2028, exhibiting a growth rate (CAGR) of 17.4% during 2023-2028.
What is cell and gene therapy?
Cell and gene therapy represents a pioneering approach to medical treatment that harnesses the potential of cellular and genetic interventions to address various health conditions. Differing from traditional medical approaches, cell and gene therapy employs advanced technologies to modify or replace faulty genes or cells within a patient's body. This method holds promise in treating a wide spectrum of diseases, from genetic disorders to certain types of cancer. Healthcare professionals and research institutions are actively utilizing these innovative therapies to provide tailored medical solutions, including personalized gene editing and cell-based regenerative treatments. The versatility and precision of cell and gene therapy offer a transformative avenue for medical advancements, presenting new possibilities for patients and medical practitioners alike.
Request for a sample report or buy full report: https://www.imarcgroup.com/cell-gene-therapy-market/requestsample
What are the growth prospects and trends in the cell and gene therapy industry?
The escalating demand for novel medical interventions, coupled with significant scientific progress, is driving the growth of the cell and gene therapy field. Additionally, healthcare organizations and research establishments are increasingly embracing cutting-edge technologies in this realm to elevate patient care and advance medical boundaries. Amid these developments, cell and gene therapy emerge as dynamic and transformative segments within the broader healthcare landscape, catalyzing the evolution of medical treatments. Moreover, adherence to rigorous regulatory frameworks and a steadfast commitment to ensuring patient safety and ethical considerations play a pivotal role in shaping the trajectory of the cell and gene therapy sector. The facilitation and promotion of these therapies are integral to addressing the evolving healthcare needs of individuals, thereby fostering the sector's expansion. Furthermore, ongoing research and development activities play a fundamental role in advancing these therapies, unlocking new avenues for addressing previously untreatable conditions.
Who are the key players operating in the industry?
The report covers the major market players including:
- Amgen Inc.
- Biogen
- Bluebird bio, Inc.
- Bristol-Myers Squibb
- Gilead Science
- Kolon TissueGene Inc.
- Orchard Therapeutics plc.
- Pfizer Inc
- Renova Therapeutics
- Spark Therapeutics, Inc.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Therapy Type:
- Cell Therapy
- Stem Cell
- Pluripotent Stem Cell
- Cancer Stem Cell
- Adult Stem Cell
- Non-Stem Cell
- T Cells
- Natural Killer
- Others
- Gene Therapy
Breakup by Indication:
- Cardiovascular Disease
- Oncology Disorder
- Genetic Disorder
- Infectious Disease
- Neurological Disorder
- Others
Breakup by Delivery Mode:
- In-Vivo
- Ex-Vivo
Breakup by End User:
- Hospitals
- Cancer Care Centers
- Pharmaceutical Biotechnology Companies
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=reportid=6964flag=C\
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: https://twitter.com/ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/